Bexarotene pretreatment significantly suppressed HBV and HDV infections in primary human hepatocytes (PHH). by Sameh A. Gad (12269979)

Statistically significant relationship between the measured CSF parameters and the peripheral white blood cell pattern, based on Spearman’s rho coefficient. by Bartosz Polis (19360325)

Fold changes were calculated as mean condition B/mean condition A, after mTIC normalization. by Manuel A. Cornejo (11636656)

M^pro confers a significant reduction in growth in yeast caused by decreases in a variety of cellular proteins. by Jin Ou (16914305)

Sensitivity analysis between Log-dNLR with cardiovascular and all-cause mortality based on model 3. by Jun Ma (9393)

The GmNN1/FT2a-GmNFYA-C-GmENOD40 module regulates soybean nodulation. by Xinxin Li (281237)

Overlap of significant unordered A) and ordered B) comorbidities. by Martina Hall (7829696)

Subjects:

Relative expression (fold-change) of immune genes in LPS-stimulated peritoneal macrophages. by Chaiwat Monmai (6377270)

Relative expression (fold-change) of immune genes in mitogen-stimulated splenic lymphocytes. by Chaiwat Monmai (6377270)

Global Land Use Change Impacts on Soil Nitrogen Availability and Environmental Losses by Jing Wang (6206297)

“…In contrast, reversing managed to natural ecosystems significantly increased NNM by 20% (9.7, 25.4%) and decreased NN by 89% (−125, −46%), indicating increasing N availability while decreasing potential N loss. …”

Restricted cubic spline curves of SHR with all-cause mortality. by Heshan Cao (17967095)

Subjects:

Kaplan-Meier survival analysis curves for all-cause mortality. by Heshan Cao (17967095)

Subjects:

Trial sequential analysis of all-cause death. by Hong Duo (13302460)

Subjects:

Subgroup analysis of the hazard risks of all-cause cause, CV death, and HHF within an 18-month follow-up period based on intention-to-treat analysis. by Chih-Wei Chen (403470)

HR (95% CI) of all-cause mortality and cause specific mortality according to vitamin D status. by Yan Wang (15435)

Subjects:

LPS up-regulated DEGs identified by RRA and fold-change analysis. by Giorgia Colombo (6337118)

Image_3_ACEI/ARB Medication During ICU Stay Decrease All-Cause In-hospital Mortality in Critically Ill Patients With Hypertension: A Retrospective Cohort Study Based on Machine Lea... by Boshen Yang (11935403)

“…A significantly lower all-cause in-hospital mortality was observed among patients treated with ACEI/ARB (3.9 vs. 12.7%) as well as a lower 28-day mortality (3.6 vs. 12.2%). …”

Image_2_ACEI/ARB Medication During ICU Stay Decrease All-Cause In-hospital Mortality in Critically Ill Patients With Hypertension: A Retrospective Cohort Study Based on Machine Lea... by Boshen Yang (11935403)

“…A significantly lower all-cause in-hospital mortality was observed among patients treated with ACEI/ARB (3.9 vs. 12.7%) as well as a lower 28-day mortality (3.6 vs. 12.2%). …”

Image_1_ACEI/ARB Medication During ICU Stay Decrease All-Cause In-hospital Mortality in Critically Ill Patients With Hypertension: A Retrospective Cohort Study Based on Machine Lea... by Boshen Yang (11935403)

“…A significantly lower all-cause in-hospital mortality was observed among patients treated with ACEI/ARB (3.9 vs. 12.7%) as well as a lower 28-day mortality (3.6 vs. 12.2%). …”

Table_1_ACEI/ARB Medication During ICU Stay Decrease All-Cause In-hospital Mortality in Critically Ill Patients With Hypertension: A Retrospective Cohort Study Based on Machine Lea... by Boshen Yang (11935403)

“…A significantly lower all-cause in-hospital mortality was observed among patients treated with ACEI/ARB (3.9 vs. 12.7%) as well as a lower 28-day mortality (3.6 vs. 12.2%). …”